Back to results
US 11,866,431 B2Granted
Bicyclic compounds
AssigneeVivace Therapeutics, Inc.
InventorsAndrei W. Konradi, Tracy Tzu-Ling Tang Lin
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
Claims12
A compound of Formula (IVa) or Formula (IVb), or a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof:
- wherein,
- RX is independently hydrogen, halogen, nitro, oxo, thioxo, imino, oximo, —OR3, —SR3, —CN, —C(═O)R2, —S(═O)R3, —S(═O)2R3, —N(R3)2, —NR3S(═O)2R3, —NR3C(═O)R3, —NR3C(═O)OR3, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6haloalkyl, substituted or unsubstituted C2-C4alkenyl, substituted or unsubstituted C2-C4alkynyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, substituted or unsubstituted C2-C10heterocycloalkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- each R2 is independently —CN, —OR3, —SR3, —S(═O)2R3, —N(R3)2, —C(═O)OR3, —N3, F, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6haloalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, substituted or unsubstituted C2-C10heterocycloalkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- each R3 is independently hydrogen, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6haloalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C3-C10cycloalkyl, substituted or unsubstituted C2-C10heterocycloalkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- R5 is F, —SF5, substituted C1-C6alkyl, substituted or unsubstituted C1-C6haloalkyl, substituted C1-C6alkyloxy, or substituted C1-C6alkylthio;
- and
- n is 0, 1, 2, 3, or 4.
4 more elements
A compound, or a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, wherein the compound is selected from the group consisting of:
Dependencies are inferred from the claim text.